Aquilus International Services and Alzheimersmeet-2019 conference organizing committee members, we are delighted to welcome all the delegates and their guests to Budapest, Hungary for the "2nd World Congress on Alzheimer's Research and Therapeutic Advances" that will take place from September 19 - 20, 2019, with Theme: "A Discussion for Developing Advanced Knowledge of Treatment Mechanisms, Processes and Recovery Methodologies Associated with Alzheimer's Disease".
Aquilus international scientific meetings provide an international platform for presentation and discussions of frontier research in the fields of medical, biological, chemical, physical sciences, and their related technologies. We are confident to say, 2nd World Congress on Alzheimer's Research and Therapeutic Advances is a distinguished event to be established as a high-quality conference in the field of alzheimers. The event has been inviting the most reputed and credited neuro practitioners and experts as keynote speakers and this could be a great opportunity to upcoming oncologists and students. Budapest will be the event host city in 2019.
The discussion about Alzheimer’s disease (AD) is important because of the quick growth percentage in worldwide especially in United States is expected to almost triple by 2050, reaching 13.8 million. According to the National Institutes of Health (NIH), South Korea and some other places in the world, because of not having awareness in patients, over the age of 65 and it is thought that up to 4.5 million people have Alzheimer's disease. Five percent of people aged 65 to 74 and roughly 35 to 50 percent of people aged over 85 have the disorder, according to the National Institute of Neurological Disorders and Stroke (NINDS) with continuous growth in the percentage over the age of 65, this figure could hit 700,000 by the year 2020.
IN the last ten years no, new drugs have been released and existing drugs only stabilize symptoms temporarily in some patients, but do not show progression of the disease. This conference is just a way to get more information about it and cure it and take up all possible research completely and as fast as possible. It is pattern of cognitive (Stages of Alzheimer's disease) and functional impairment.
As we know, Alzheimer’s disease is a disorder which is related to brain caused due to Neurogenerative disorder which means progressive brain cell death (death of the cell in brain). There are nerve tissues in the brain that has tiny deposits called as Plague and Tangles, where plague is made up of protein called ‘Beta amyloid’ which is found in dying brain cell, similarly tangles is made up of protein called ‘Tau’ which is found in between the nerve cells by which the nerve becomes week and works or responds slowly, this leads to many problems in human being. It leads to destroying memory of a person, who would forget day-to day works, people, friends, family, live around and also leads to change in mood, behavior, ability of thinking, dysarthia (difficulty in speaking), difficulty in swallowing etc. It is sad that, still, we do not permanent cure, but it has treatment for symptoms.
The people with this disorder require more attention like long-term care, its heredity, changes in their life style, environmental factors the most risk factor in this is disorder is AGE. Inability to interpret signals from the body, such as when the bladder is full or pain signals that imply serious conditions (e.g., chest pain), Hallucinations may be visual or aural and may be exacerbated by loss of hearing or sight, no prevention trial has been completed. Those who eat a diet high in saturated fats and simple carbohydrates have a higher risk. The stages of Cognitive: No cognitive impairment, Very mild decline, Mild cognitive decline, Moderate cognitive decline, Moderately severe cognitive decline and Severe cognitive decline.
The latest diagnostic criteria, is preclinical, MCI, and AD dementia, Recent advances in modern imaging techniques have pushed AD imaging to the forefront of AD research and greatly increased our knowledge of the pathogenesis of AD High resolution MRI has allowed the differentiation of minute structures of the brain, while molecular imaging using PET has allowed clinicians and researchers to stage AD antemortem.
The conference will bring together delegates from all over the world from Universities, Hospitals, research fields, civil societies and public authorities to explore and discuss opportunities and strengths related to Alzheimer's. During the conference, you can learn and discuss appealing topics and through your participation, you can help develop issues to be further explored.
